Hollings Horizons

To read the digital version of Hollings Horizons magazine, click on the magazine cover below or visit our Hollings Horizons flipbook webpage.

Video Spotlight

An ovarian cancer diagnosis was the last thing that Carol Sullivan expected. But with support from friends and family and her care team at MUSC Hollings Cancer Center, she's successfully come through treatment. Watch her inspiring story below.

Director's Message — Fall 2023

As the only National Cancer Institute (NCI)-designated cancer center in South Carolina, and one of 72 in the country, our work is deeply rooted in evidence-based practice and in driving scientific discoveries that translate directly to patient care across the state. This elite status sets us apart as we fulfill our mission to reduce the cancer burden in South Carolina with special emphasis on the needs of underserved populations.

This past spring, the Hollings team submitted our application to the NCI for the five-year renewal of our Cancer Center Support Grant (CCSG) and, in September, hosted reviewers who evaluated every aspect of our operations, clinical programs, research and education. This rigorous evaluation process is conducted by nationally recognized peer reviewers who evaluate cancer centers for basic and translational science programs, clinical and population-based research, cancer education, community outreach, and the center’s clinical growth and translation of research to patient care.

The CCSG supports our mission by funding cutting-edge research and clinical programs that offer patients the latest forms of cancer treatments and access to clinical trials, training scientists and physicians, and providing education and outreach about cancer prevention and screenings.

I am proud to say that we were able to share significant growth and advances with the NCI representatives since our last review five years ago and are optimistic about their final review of Hollings and what that means for the people we serve.

But with cancer, there is always much work to do. We are grateful to have the support of many, especially our state and federal leaders. We will continue to lead and innovate with scientific breakthroughs and provision of the highest level of care in the state, which results in helping thousands of patients in South Carolina and beyond when faced with a cancer diagnosis.

Thank you to all who support our important mission.

Best Wishes,

Raymond N. DuBois, M.D., Ph.D.
Director, MUSC Hollings Cancer Center
Associate Provost of Cancer Programs, MUSC